IRCT2013091113572N3已完成未知
The Evaluation of Valproic acid Pharmacokinetic Key Parameters as a Seizure Prophylactic Agent Following Subarachnoid Hemorrhage
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 100 years（—）
- 性别
- All
入选标准
- •Patients with subarachnoid hemorrhage; GCS = 12; Age over 18
排除标准
- •Scr=1.5 mg/dl or urine output>0.5cc/Kg/hr; Plattlet count<100,000; INR=2; Albumin<3; Age >18; Liver Function Test>3×Normal Range; Mean Arterial Pressure<70; Occurance of seizure during the study; Previous CNS diseases such as Parkinson's, Multiple sclerosis, CNS tumors, Infections involving the brain and CNS; History of using anti-epileptic drugs; Pregnancy; History of urea cycle disorders
研究者
相似试验
进行中（未招募）
不适用
Preclinical and clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of head and neckRecurrent and/or metastatic squamous cell carcinoma of head and neckMedDRA version: 17.0Level: PTClassification code 10067821Term: Head and neck cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-001523-69-ITIstituto Nazionale Tumori di Napoli - Fondazione G. Pascale39
已完成
1 期
A Drug Interaction Study of Valproic Acid and Single-dose Paliperidone Extended-Release (ER) in Healthy MenSchizophreniaEpilepsyNCT01060228Johnson & Johnson Pharmaceutical Research & Development, L.L.C.24
已完成
1 期
Pharmacokinetic Interactions in Combination Treatment of Valproic Acid and Ertapenem in Normal SubjectsHealthyNCT01073059Chonbuk National University10
尚未招募
3 期
Ayurvedic management of Epilepsy in childreCTRI/2023/03/050961Dr Suryanarayana Mudadla
招募中
1 期
Randomized phasE 2 study of Valproic acid in combination with bevacizumab and Oxaliplatin/fLUoropyrimidine regimens in patients with ras-mutated metastaTIc cOlorectal caNcerpatients with ras-mutated metastaTIc colorectal cancerMedDRA version: 20.0Level: LLTClassification code 10007446Term: Carcinoma of rectumSystem Organ Class: 100000004864EUCTR2018-001414-15-ITISTITUTO NAZIONALE TUMORI - IRCCS FONDAZIONE PASCALE200